Maxpro Ventures
Venture capitalTaipei · Seed–Late Stage · 7 people tracked
Investment thesis
Maxpro Ventures focuses on biomedical and healthcare innovation, backing companies across areas such as biologic drugs, cell therapy, small molecule drugs, and medical devices. The firm pairs seasoned biomedical scientific expertise with venture capital investment experience to identify and scale transformative healthcare companies in global markets. Beyond capital, it provides strategic guidance to accelerate portfolio companies' development and help bring breakthrough healthcare solutions to patients worldwide, aiming to advance patient outcomes while delivering strong financial returns.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's websiteWhat they invest in
from 4 of 33 portfolio companiesBiotech ×4Healthtech ×3AI & Machine Learning ×1Deep Tech ×1
HQs:United States×1
Investments · 33 tracked
founders shown can be your intro pathBiotechFoster City, US
Hung-Wen (Howard) Chen(Executive Officer, Director)Hung-Hsien Yen(Director)Yi-Kuei (Alex) Chen(Executive Officer, Director)Hong-Jung (Moses) Chen(Director)Hsien-Shu (Jerry) Tsai(Director)Ya-Chi (Claudia) Huang(Director)
Acepodia is a clinical-stage biotechnology company developing cell therapies for cancer using its Antibody-Cell Conjugation (ACC) platform, which attaches tumor-targeting antibodies to immune cells without genetic engineering.
BiotechHealthtech
AngenMed develops neoantigen-targeting cell-based cancer immunotherapies, including dendritic cell vaccines and neoantigen-specific T cell products personalized to each patient's tumor mutations.
BiotechDeep TechHealthtech
GenScript provides customizable life science research services and platforms, including gene synthesis and validation support for AI drug discovery, serving researchers and biotech developers.
AI & Machine LearningBiotechHealthtech
Exits · 1
IPOs and acquisitions across the tracked portfolioApollomicsNASDAQ: APLM
Frequently asked questions
- How many investments has Maxpro Ventures made?
- Maxpro Ventures has 33 tracked investments, including 1 dated in the last 24 months.
- What stage does Maxpro Ventures invest at?
- Maxpro Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Maxpro Ventures's typical check size?
- Maxpro Ventures typically writes checks of $10M – $13M.
- What sectors does Maxpro Ventures focus on?
- Maxpro Ventures focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices, Retail Tech.
- Where is Maxpro Ventures located?
- Maxpro Ventures is headquartered in Taipei, TW.
Images
Similar investors
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Seventure Partners is a European venture capital firm investing across life sciences, digital technologies, sport and performance, and the blue economy.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.